Refine by
Patient Engagement Articles & Analysis
37 news found
Summary Dentists and surgeons devote their professional lives to improving patient health, often engaging in complex procedures that require precision, concentration, and prolonged static or awkward positioning. ...
The HFSA Optimal Medical Therapy in Heart Failure (OMT-HF) program can help your patients achieve their best outcomes. An estimated 6.5 million Americans have heart failure (HF). This year alone another 960,000 will likely be diagnosed with this condition. Chances are several of your patients are in this group. Are they receiving the optimal medical therapy (OMT), that helps them achieve ...
Supported by Insilico Medicine and other technology leaders, Longenesis has built an end-to-end, intuitive toolkit for data discovery and patient-centric engagement in medical studies. Our flagship products, Curator and Engage, are highly secure and designed for patients to remain in control of their personal data while also ...
Higher APC rates have been shown to lead to improved patient outcomes; a recent study showed that the incidence of colorectal cancer within three years of examination decreases with higher APC rates.5 “Even among the best endoscopists, there is room for improvement in adenoma detection, which can impact patient outcomes,” said Sloane Allebes ...
“We are thrilled to partner with Vault Health and Faeth Therapeutics to help recently diagnosed pancreatic cancer patients access the NEAAR-001 study as a patient-centric and decentralized clinical trial,” said Mika Newton, CEO of xCures. ...
ByxCures
“During our clinical study using the Bodyport Cardiac Scale, we found patients more engaged, and our clinical team better empowered to make timely, individualized treatment adjustments to get ahead of changes in a patient’s condition before they worsen. ...
” “I am enthusiastic about the prospects for ReShape’s continued growth including its full suite of weight loss solutions, especially the Lap-Band® program and the demand generated by the multi-tiered direct-to-consumer (DTC) marketing campaign, thus far, which continues to be successful in driving patient engagement and filling ...
Longenesis announced its initial partnership to study diabetic patients’ quality of life with Medtronic in 2021. Medical research often suffers from low patient engagement rates due to a lack of individualised engagement options, resulting in a lack of helpful data that healthcare stakeholders can use to make vital care ...
Supported by Insilico Medicine and other technology leaders, Longenesis has built an end-to-end, intuitive toolkit for data discovery and patient-centric engagement that prioritises privacy and ethics. Our flagship products, Curator and Engage, are highly secure and designed for patients to remain in control of their personal ...
It allows spot or continuous monitoring of the patient's vital physiological parameters, the management of pharmacological and rehabilitative therapies and ECG reporting and is linked to a Service Center (clinical and technical) active 24h and 7/7 to respond promptly to the patient's needs and to make a quick escalation to competent doctors. ...
Health Unmuted is an audio library of short-format podcast miniseries, each of which covers a specific health topic and features the voices of patients, caregivers and medical professionals. "We're excited to launch the Alzheimer's Podcast as the newest addition in the Health Unmuted library. ...
She brings decades of global experience in clinical research and development, commercialization, patient engagement, and regulatory strategy. Prior to joining Altoida, Dr. Chadha served as the Head of Stakeholder Engagement for Alzheimer’s Disease at Biogen. She is the co-founder and pro-bono CEO of the Women’s Brain Project, a ...
The solution is to expand the number of patients to support development of general principles to guide decision-making. ...
The Notal Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with wet age-related macular degeneration (AMD), complementing existing standard of care treatments as well as emerging longer acting drugs and drug delivery systems. ...
Isabel Healthcare and Riverwood Healthcare have partnered to integrate Isabel’s AI symptom checker / self-triage platform into the Riverwood website to enhance care access and patient engagement. The symptom checker has been customized for Riverwood with integration of live chat and care option selection links and other pertinent content to help ...
It is the preferred modality for treating pediatric patients, who are particularly susceptible to the potential side effects of radiation therapy. "Bringing the most advanced technology to serve our patients with the highest quality care is essential,” said Mark Bonnen, MD, chief medical officer of the Mays Cancer Center. ...
During 2021, we achieved several major installed base milestones including our 12 millionth Invisalign patient, 68 thousandth iTero scanner sold, and 47 thousandth exocad software license sold. ...
Each of these innovations is designed to enhance Invisalign treatment planning quality, efficiency, and scale, and contribute to a better doctor-patient engagement and treatment outcomes. Raj Pudipeddi, Align Technology chief product and marketing officer, senior vice president and managing director, Asia Pacific said, “Align is proud to be at the ...
Operational and Financial Updates Substantive review with the FDA for the PMA supplement for the next generation Eversense 180-day CGM system is nearing completion, all queries raised have been answered and a decision regarding approval is expected in the coming weeks Designing plans with Ascensia Diabetes Care for a smooth transition to the 180-day system in the U.S., pending FDA ...
About the Alta Study The Phase 1/2 Alta study is an open-label, dose-ranging, multicenter clinical trial designed to assess the safety and tolerability of giroctocogene fitelparvovec in patients with severe hemophilia A. The mean age of the 11 male patients assessed across four dose cohorts (9e11 vg/kg - 2 patients, 2e12 vg/kg - 2 ...